Greater Chicago Area, United States, March 2025 – Vantive has appointed Sasha Diskin as Vice President, Human Resources, bringing a wealth of experience in talent strategy, organizational transformation, and diversity & inclusion. In this role, she will oversee Vantive’s HR strategy, focusing on talent acquisition, employee engagement, and leadership development to support the company’s mission of expanding possibilities in vital organ therapies.
Sasha joins Vantive from Amgen, where she served as Vice President, Talent, Diversity & Inclusion, leading post-merger integration efforts following Amgen’s $27.8 billion acquisition of Horizon Therapeutics. At Horizon, she played a key role in organizational culture transformation, succession planning, and corporate reputation initiatives, helping grow the company from a $500M emerging player to a $3B+ global healthcare leader.
Earlier, she held leadership roles at Baxter International, where she led change management initiatives, talent strategies, and global workforce transformation. She also served as HR consultant at Willis Towers Watson, advising Fortune 500 companies on HR transformation, performance management, and employee engagement. Her experience spans across life sciences, healthcare, and financial services, making her a valuable asset to Vantive.
Sasha holds an MBA in Change Management & Leadership Development from DePaul University. Her expertise in HR leadership and strategic workforce planning will play a crucial role in Vantive’s mission to innovate in kidney care and vital organ therapies.
About Vantive
Vantive is a leading global healthcare company dedicated to transforming kidney care and vital organ therapies. With a legacy spanning 70 years, Vantive has been at the forefront of developing life-saving innovations that enhance dialysis treatment, organ preservation, and patient outcomes.
Formerly part of Baxter International, Vantive has evolved into an independent powerhouse in renal care and critical therapies, providing advanced digital solutions, next-generation dialysis technologies, and therapy administration innovations. The company’s solutions are designed to enhance the efficiency of healthcare teams, improve patient access to quality care, and extend lives.
With a strong global footprint, Vantive serves millions of patients and healthcare professionals worldwide, leveraging cutting-edge research, strategic partnerships, and AI-driven healthcare solutions to expand treatment possibilities. As the company continues to broaden its impact beyond kidney care, it remains committed to advancing vital organ therapies through scientific breakthroughs and patient-centered innovation.
Read Also : Entering 2025, TA Leaders’ Success Built on More than Just Hiring, Says The Josh Bersin Company
People Analytics Teams Still Struggle to Deliver Business Impact, Warns The Josh Bersin Company
ESG and Women’s Leadership: Driving Sustainability and Inclusion
Learning and Development Trends for 2025: Shaping the Future of Workplace Learning
